BIM:EPA
BioMerieux SA
€69.10
arrow_downward
-3.83%(-2.75) 1D
Jul 31, 5:35:50 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BIM...
Open
€71.75
High
€71.85
Low
€69.10
Mkt. cap
8.39B
Avg. vol.
207.36K
Volume
224.35K
P/E ratio
17.71
52-wk high
€128.30
52-wk low
€65.60
EPS
€3.90
Shares outstanding
118.36M
No. of employees
15K
Open
€71.75
High
€71.85
Low
€69.10
Mkt. cap
8.39B
Avg. vol.
207.36K
Volume
224.35K
P/E ratio
17.71
52-wk high
€128.30
52-wk low
€65.60
EPS
€3.90
Shares outstanding
118.36M
No. of employees
15K
News stories
From sources across the web
Simply Wall St
·
27 minutes ago
Is Okta (OKTA) Still Below Fair Value Following Its Permiso Acquisition?
Benzinga
·
24 minutes ago
Stock Market This Week: Top Three Catalysts for S&P 500 and Dow Jones
Seeking Alpha
·
44 minutes ago
Financial sector tops the S&P 500 in July, led by PayPal's 30% rally
Profile
bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors.
bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases, cancer screening, and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock exchange. Wikipedia
About BioMerieux SA
CEOPierre Boulud
Employees14.9K
Founded1963
HeadquartersMarcy-l'Étoile, Rhone-Alpes, France
SectorMedical device
Websitebiomerieux.com
AI content may include mistakes. Learn more